Track the Creo Medical Group plc share price and the full management transaction log of the company, a publicly traded company based in United Kingdom. Shares are quoted on UK GB, under the authority of RNS (LSE). Market capitalisation: €71m. The latest transaction was disclosed on 2 June 2025 (Purchase). Among the most active insiders: Richard Rees. The full history is free.
8
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
2 ops.
Sell Volume
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,664 of 26,212 companies
48.5
score / 100
Value
44
Quality
54
FCF yld-28%
Earn yld7.5%
EV/EBITDA·
ROE-77%
Gross mgn40%
Net mgn88%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Creo Medical Group plc is a company focused on developing innovative medical technologies for cancer treatment. It aims to create devices that enhance patient outcomes through less invasive approaches.